-
-
-
-
-
-
-
Median Technologies to Showcase eyonis® LCS, Its AI/ML-based Software as a Medical Device for Lung Cancer Screening, at the European Congress of Radiology
-
-
-
-
-
-
-
Median Technologies Partners With Leading U.S. Healthcare Company to Bring eyonis® LCS to Patients Across the U.S. and Europe
-
-
-
-
-
-
-
Median Technologies Has Completed a Capital Increase of € 23.9 Million
-
-
-
-
-
-
-
Median Technologies Reports Full-year 2024 Financial Results
-
-
-
-
-
-
-
Median Technologies Hosted Insightful Key Opinion Leader (KOL) Webinar on eyonis™ Lung Cancer Screening (LCS) REALITY Data
-
-
-
-
-
-
-
Median Technologies Reports 2023 Revenue and Summarizes 2024 Strategic Outlook
-
-
-
-
-
-
-
Median Technologies Reports Full-Year 2021 Results and Business Indicators for the First Quarter of 2022
-
1,216,197 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

